Author: Dr Alexander Natz, LL.M.
On 26 April 2023, the draft of the EU Pharmaceutical Legislation was published.
This white paper addresses the new concept of the legislation, which will also include the Orphan Medicines Regulation and the Paediatric Regulation.
The roadmap for implementation is addressed here - although this will be somewhat interrupted by the EU parliamentary elections next year. Two major points of the legislation will be the concept of 'unmet medical need' and the modified Regulatory Data Protection Schemes. Overall, the legislation is expected to have a high impact on drug development and marketing in Europe.
Download now the white paper 'EU Pharmaceutical Legislation – The most important changes at a glance'.
We hope you enjoy reading it!
With this qualification course, you can continue your education in a structured manner in all CMC topics, with a technical focus on development methods, manufacturing processes, CMC documents, change management, and much more.
Attend one of our free pre-meetings to familiarise yourself with the Learning Space and the various ways in which you can interact during the event
Explore the transformative potential of artificial intelligence in pharmacovigilance. This course provides an in-depth understanding of AI technologies, regulatory requirements, and practical applications in drug safety. Through expert insights and hands-on workshops, you'll learn how to leverage AI to enhance your pharmacovigilance processes. Register now to future-proof your PV operations.
Update your knowledge: Our team of experts provides you with important and practical information about the tasks and responsibilities of an EU-QPPV.
During our online training "Toxicology and beyond: Safety assessment in drug development" you will build a solid toxicological know-how basis and will be informed about the inclusion of toxicological data in the marketing authorisation dossier. Take the chance and participate in our interactive online training.
You as "beginner" or "refresher" would like to feel more secure writing CMC documents? Our experts will provide you with practical tips and tricks and share their experiences with you. After attending this virtual seminar you will be able to present data clearly and in compliance with the regulations.
Are you looking for a compact knowledge update on the regulations and guidelines in clinical drug trials to perform your daily work in a compliant and responsible manner? Then get comprehensive information in this webcast series!
Global variations and lifecycle management - covering key regions: USA, Asia (China, Japan, South Korea), LATAM (Central America, Brazil), and Gulf Cooperation Council (GCC). Take this opportunity to discuss your specific daily business challenges with our experts and network with peers to see how others approach similar issues!
Four live webcasts à 2 hours every week: CMC requirements in China, India, Japan, South Korea and Russia/EAEU. Meet our four experts to get an update on the current requirements in the different regions and discuss your individual issues with them. You are interested in one webcast only or a group account? Contact us!
Reporting adverse drug reactions forms the foundation of drug safety. In this one-day online seminar, you will learn the regulatory requirements and best practices for ICSR reporting. Whether you are new to the topic or looking for a refresher, you will benefit from the extensive practical experience of our speakers from both Big Pharma and consulting!
The online seminar with details on development, quality, CMC, approval and market access (including an update on the upcoming EU HTA) for advanced therapy medicinal products. Qualifiy now!
